KFDA to order label change of Janssen Korea contraceptive patch

Published: 2005-12-19 07:00:00

Updated: 2005-12-19 07:00:00

The U.S. FDA earlier instructed to change the label of Janssen's Evra patch, a contraceptive patch, after warning that it might increase an estrogen exposure to the body.

Now KFDA follows the same label change applicable to Evra patch in Korea (ethinyl estradiol 0.6mg and norelgestromin) sold...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK